Predictive Oncology Cash Flow from Operating Activities 2010-2023 | POAI
Predictive Oncology cash flow from operating activities from 2010 to 2023. Cash flow from operating activities can be defined as a company's cash flows from operations.
| Predictive Oncology Annual Cash Flow Ops (Millions of US $) |
|
|---|---|
| 2023 | $-13 |
| 2022 | $-12 |
| 2021 | $-12 |
| 2020 | $-12 |
| 2019 | $-9 |
| 2018 | $-5 |
| 2017 | $-4 |
| 2016 | $-4 |
| 2015 | $-7 |
| 2014 | $-3 |
| 2013 | $-4 |
| 2012 | $-1 |
| 2011 | $-2 |
| 2010 | $-1 |
| 2009 | $-1 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.007B | $0.002B |
| Predictive Oncology Inc. is focused on applying artificial intelligence to personalized medicine and drug discovery. Its operating business unit consists of Helomics, TumorGenesis and Skyline Medical. Predictive Oncology Inc., formerly known as Precision Therapeutics Inc., is based in MINNEAPOLIS. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GE HealthCare Technologies (GEHC) | United States | $36.987B | 20.31 |
| Inspire Medical Systems (INSP) | United States | $4.742B | 0.00 |
| Axonics (AXNX) | United States | $3.435B | 0.00 |
| 10x Genomics (TXG) | United States | $3.214B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $3.075B | 0.00 |
| Olink Holding AB (publ) (OLK) | Sweden | $2.923B | 0.00 |
| Enovis (ENOV) | United States | $2.836B | 21.02 |
| Hims & Hers Health (HIMS) | United States | $2.769B | 0.00 |
| Azenta (AZTA) | United States | $2.768B | 155.58 |
| Privia Health (PRVA) | United States | $2.147B | 119.93 |
| Schrodinger (SDGR) | United States | $1.685B | 0.00 |
| Omnicell (OMCL) | United States | $1.414B | 48.89 |
| Phreesia (PHR) | United States | $1.241B | 0.00 |
| Standard BioTools (LAB) | United States | $0.719B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.664B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.640B | 0.00 |
| Talkspace (TALK) | United States | $0.484B | 0.00 |
| Clover Health Investments (CLOV) | United States | $0.452B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.401B | 0.00 |
| Pulmonx (LUNG) | United States | $0.340B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.299B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.201B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.199B | 0.00 |
| Outset Medical (OM) | United States | $0.160B | 0.00 |
| American Well (AMWL) | United States | $0.145B | 0.00 |
| TruBridge (TBRG) | United States | $0.133B | 7.15 |
| Augmedix (AUGX) | United States | $0.115B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.113B | 0.00 |
| 111 (YI) | China | $0.108B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.077B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.071B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.061B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.058B | 0.00 |
| HeartBeam (BEAT) | United States | $0.053B | 0.00 |
| Zepp Health (ZEPP) | China | $0.052B | 0.00 |
| Movano (MOVE) | United States | $0.041B | 0.00 |
| CareCloud (CCLD) | United States | $0.037B | 0.00 |
| Akili (AKLI) | United States | $0.034B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.033B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.023B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.020B | 0.00 |
| Cue Health (HLTH) | United States | $0.019B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.013B | 0.00 |
| Biotricity (BTCY) | United States | $0.010B | 0.00 |
| Transgenomic (PRPO) | United States | $0.009B | 0.00 |
| Syra Health (SYRA) | United States | $0.009B | 0.00 |
| HeartSciences (HSCS) | United States | $0.005B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.004B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.001B | 0.00 |
| Centogene (CNTG) | Germany | $0.000B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |